148 Participants Needed

Acceptance-Based Treatment for Adolescent Obesity

SM
Overseen ByStephanie Manasse, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but if you have recently started or changed the dosage of any medication that affects appetite or body composition, you may not be eligible to participate.

What data supports the effectiveness of the treatment Acceptance-Based Treatment for Adolescent Obesity?

Research shows that acceptance-based therapy (ABT) has been effective for weight loss in adults and is feasible and acceptable for adolescents. In a study, adolescent girls who participated in an ABT intervention showed a decrease in BMI and improvements in psychological flexibility compared to those who received enhanced care.12345

Is Acceptance-Based Treatment safe for humans?

Acceptance-Based Treatment (ABT) has been studied for obesity in both adults and adolescents, and it has been found to be feasible and acceptable, indicating it is generally safe for humans.12346

How is Acceptance-Based Treatment different from other treatments for adolescent obesity?

Acceptance-Based Treatment (ABT) for adolescent obesity is unique because it focuses on improving psychological flexibility and increasing physical activity intentions, rather than just providing standard lifestyle advice. It involves virtual group sessions that help adolescents accept their thoughts and feelings, which can lead to better weight management outcomes.12347

What is the purpose of this trial?

The goal of this clinical trial is to learn about cardiovascular disease risk among adolescent girls with overweight/obesity. The main questions this trial aims to answer are:1. Does an acceptance-based healthy lifestyle intervention demonstrate more weight loss than a health education intervention?2. Does an acceptance-based healthy lifestyle intervention show more improvements in participants' physiological, health-related, and psychological factors compared to a health education intervention?Participants in this trial will:1. Engage in treatment for 6-months, comprising of a mixture of in-person and remote group sessions, occurring at Drexel University or over a video-conferencing platform.2. Complete various assessments. These include self-reported questionnaires, measures of weight, height, body composition, blood pressure, and blood lipids, and wearing of smart watches to measure sleep and physical activity.Researchers will compare the acceptance-based and health education intervention groups to see if the acceptance-based treatment will indeed be effective in improving participants' health outcomes.

Research Team

SM

Stephanie Manasse, PhD

Principal Investigator

Drexel University

Eligibility Criteria

This trial is for adolescent girls aged 14-19 who are experiencing obesity, with a BMI percentile at or above the 85th percentile for their sex and age. It's designed to help them lose weight and improve cardiovascular health.

Inclusion Criteria

My BMI is in the top 15% for my age and sex.
I am between 14 and 19 years old.
I identify as a girl.

Exclusion Criteria

Plans to move out of the area within the next year
Unwillingness to report possible or confirmed pregnancies promptly during the course of the trial
Recent or ongoing problem with drug abuse, alcohol abuse, or addiction
See 14 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 6-month intervention, including acceptance-based therapy or health education, with a mix of in-person and remote group sessions

6 months
18 sessions (in-person and remote for ABT), 9 sessions (in-person and remote for HE)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 6-month and 12-month intervals

12 months
Assessments at month 12 and month 18

Treatment Details

Interventions

  • Acceptance-Based Treatment
Trial Overview The study compares two methods: an acceptance-based healthy lifestyle intervention (ABT) versus standard health education (HE). Over six months, participants will attend both in-person and remote sessions to see which method leads to more weight loss and better health outcomes.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Acceptance-based Treatment (ABT)Experimental Treatment1 Intervention
ABT will consist of 18, 90-minute group sessions over 6 months.
Group II: Health Education (HE) ComparisonPlacebo Group1 Intervention
HE will include nine, 75-minute group health education sessions handouts over 6 months.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Drexel University

Lead Sponsor

Trials
160
Recruited
48,600+

Findings from Research

Participants with overweight and obesity who underwent a revised acceptance-based behavioral treatment (ABT) lost significantly more weight over 12 months (13.3%) compared to those receiving standard behavioral treatment (SBT) (9.8%), indicating that ABT is more effective for long-term weight loss.
ABT not only led to greater weight loss but also helped participants maintain a 10% weight loss better than SBT (64.0% vs. 48.9%), suggesting that the self-regulation skills taught in ABT, such as psychological acceptance and motivation, play a crucial role in successful weight management.
Acceptance-based versus standard behavioral treatment for obesity: Results from the mind your health randomized controlled trial.Forman, EM., Butryn, ML., Manasse, SM., et al.[2022]
The acceptance-based therapy (ABT) intervention for adolescent girls with overweight/obesity was feasible and acceptable, achieving a recruitment of 13 participants and an 85% retention rate over 6 months.
Participants showed a mean decrease in BMI Z-score of -0.15, along with improvements in body fat percentage, quality of life, psychological flexibility, and depression, indicating the intervention's potential effectiveness.
Feasibility/acceptability of an acceptance-based therapy intervention for diverse adolescent girls with overweight/obesity.Cardel, MI., Lee, AM., Chi, X., et al.[2022]
In the Mind Your Health Trial involving 190 participants, acceptance-based treatment (ABT) for obesity led to a significantly higher proportion of individuals maintaining a 10% weight loss at 36 months compared to standard behavioral treatment (SBT) (31.6% vs. 17.1%).
ABT also resulted in improved quality of life at 24 and 36 months, suggesting that while initial weight loss benefits may diminish over time, the psychological and motivational aspects of ABT contribute to better long-term outcomes.
Long-Term Follow-up of the Mind Your Health Project: Acceptance-Based versus Standard Behavioral Treatment for Obesity.Forman, EM., Manasse, SM., Butryn, ML., et al.[2023]

References

Acceptance-based versus standard behavioral treatment for obesity: Results from the mind your health randomized controlled trial. [2022]
Feasibility/acceptability of an acceptance-based therapy intervention for diverse adolescent girls with overweight/obesity. [2022]
Long-Term Follow-up of the Mind Your Health Project: Acceptance-Based versus Standard Behavioral Treatment for Obesity. [2023]
Wellness Achieved Through Changing Habits: A Randomized Controlled Trial of an Acceptance-Based Intervention for Adolescent Girls With Overweight or Obesity. [2023]
The mind your health project: a randomized controlled trial of an innovative behavioral treatment for obesity. [2022]
A randomized trial of an acceptance-based behavioral intervention for weight loss in people with high internal disinhibition. [2022]
Physical Activity Intentions and Behavior Mediate Treatment Response in an Acceptance-Based Weight Loss Intervention. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security